FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Former FDA Device Head Villforth Passes

Former CDRH director John C. Villforth passes at the age of 88.

FDA General

FDA Proposes Rule on E-cigarette Pathway

FDA issues a proposed rule setting requirements related to the content, format and review and communications procedures for premarket tobacco product ...

Medical Devices

5 Guidances Updating 510(k) Program

FDA releases five guidances relating to expanding the 510(k) program that the Safety and Performance Based Pathway.

Human Drugs

FDA Wants CNS Stimulant Abuse Deterrence Comments

FDA solicits comments on abuse-deterrent formulations for prescription stimulants.

Federal Register

Info Collection Extension on MedSun Reporting

Federal Register notice: FDA seeks comments on an information collection extension for it MedSun adverse event program for medical devices.

Federal Register

Guide on Safer Technologies Device Program

Federal Register notice: FDA posts a draft guidance entitled Safer Technologies Program for Medical Devices, a new, voluntary program for certain devi...

Federal Register

Final Guide on 505(q) Citizen Petitions

Federal Register notice: FDA makes available a final guidance entitled Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of...

Human Drugs

FDA Updates RLD Access Inquiry List

FDA updates its list of drugs for which the agency has received a reference-listed drug access inquiry.

Human Drugs

Pelosi Releases Drug Pricing Bill

House Speaker Nancy Pelosi releases her initial legislation to lower drug prices in ways she hopes will attract support from President Trump.

Human Drugs

Genentech Breakthrough Status for Lupus Nephritis Drug

FDA grants Genentech a breakthrough therapy designation for Gazyva (obinutuzumab) for adults with lupus nephritis.